scispace - formally typeset
C

Changlian Zhu

Researcher at University of Gothenburg

Publications -  208
Citations -  16429

Changlian Zhu is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Neuroprotection & Apoptosis. The author has an hindex of 50, co-authored 183 publications receiving 13346 citations. Previous affiliations of Changlian Zhu include Boston Children's Hospital & Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

Disruption of Interleukin-18, but Not Interleukin-1, Increases Vulnerability to Preterm Delivery and Fetal Mortality after Intrauterine Inflammation

TL;DR: It is demonstrated that preterm pregnancy loss in response to intrauterine inflammation was enhanced by disruption of the IL-18 gene and/or IL- 18 neutralization, events that may relate to exaggerated Th1 responses because of an increased IL-12/IL-18 ratio.
Journal ArticleDOI

NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia.

TL;DR: The data imply that NMDA receptors are involved in the activation of apoptotic processes in the immature brain after HI, and reduce injury, cells positive for active caspase-3, and DNA fragmentation in the cerebral cortex.
Journal ArticleDOI

The Use of the WINROP Screening Algorithm for the Prediction of Retinopathy of Prematurity in a Chinese Population

TL;DR: The WINROP system had a sensitivity of 87.5% in a Chinese population for the early identification of infants that developed severe ROP and was identified in this alarm group.
Journal ArticleDOI

γδ T Cells Contribute to Injury in the Developing Brain.

TL;DR: Analysis of postmortem brains from human preterm infants with periventricular leukomalacia and two animal models of preterm brain injury highlighted unique features of injury in the developing brain, where γδT cells function as initiators of injury independently of common γ δT-cell–associated cytokines.
Journal ArticleDOI

X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants

TL;DR: It is demonstrated that X’chromosome‐linked inhibitor of apoptosis protein (XIAP) counteracts oxidative stress in two essentially different disease‐related models of brain injury, hypoxia‐ischemia and irradiation, and may provide the basis for development of novel protective strategies for both acute and chronic neurodegenerative diseases.